Table of Contents 1 Kidney/Renal Fibrosis Treatment Market Overview 1.1 Product Overview and Scope of Kidney/Renal Fibrosis Treatment 1.2 Classification of Kidney/Renal Fibrosis Treatment by Types 1.2.1 Global Kidney/Renal Fibrosis Treatment Revenue Comparison by Types (2019-2024) 1.2.2 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Types in 2018 1.2.3 Angiotensin II Receptor Blockers (ARBs) 1.2.4 Angiotensin Converting Enzyme (ACE) Inhibitors 1.2.5 Pirfenidone 1.2.6 Renin Inhibitors 1.2.7 Vasopeptidase Inhibitors 1.3 Global Kidney/Renal Fibrosis Treatment Market by Application 1.3.1 Global Kidney/Renal Fibrosis Treatment Market Size and Market Share Comparison by Applications (2014-2024) 1.3.2 Commercial/Private Hospitals 1.3.3 Public Health Hospitals 1.3.4 Clinics 1.3.5 Home Treatment 1.4 Global Kidney/Renal Fibrosis Treatment Market by Regions 1.4.1 Global Kidney/Renal Fibrosis Treatment Market Size (Million USD) Comparison by Regions (2014-2024) 1.4.1 North America (USA, Canada and Mexico) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024) 1.4.2 Europe (Germany, France, UK, Russia and Italy) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024) 1.4.4 South America (Brazil, Argentina, Colombia) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024) 1.4.5 Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa) Kidney/Renal Fibrosis Treatment Status and Prospect (2014-2024) 1.5 Global Market Size of Kidney/Renal Fibrosis Treatment (2014-2024) 2 Company Profiles 2.1 La Jolla Pharmaceutical Company 2.1.1 Business Overview 2.1.2 Kidney/Renal Fibrosis Treatment Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.2 Genzyme Corporation 2.2.1 Business Overview 2.2.2 Kidney/Renal Fibrosis Treatment Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Genzyme Corporation Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.3 Pfizer Inc. 2.3.1 Business Overview 2.3.2 Kidney/Renal Fibrosis Treatment Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Pfizer Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.4 Merck & Co. 2.4.1 Business Overview 2.4.2 Kidney/Renal Fibrosis Treatment Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Merck & Co. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.5 Galectin Therapeutics 2.5.1 Business Overview 2.5.2 Kidney/Renal Fibrosis Treatment Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Galectin Therapeutics Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.6 F. Hoffman-La Roche Ltd. 2.6.1 Business Overview 2.6.2 Kidney/Renal Fibrosis Treatment Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.7 ProMetic Life-Sciences Inc. 2.7.1 Business Overview 2.7.2 Kidney/Renal Fibrosis Treatment Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.8 InterMune Inc. 2.8.1 Business Overview 2.8.2 Kidney/Renal Fibrosis Treatment Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 InterMune Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) 2.9 BioLine Rx Ltd 2.9.1 Business Overview 2.9.2 Kidney/Renal Fibrosis Treatment Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) 3 Global Kidney/Renal Fibrosis Treatment Market Competition, by Players 3.1 Global Kidney/Renal Fibrosis Treatment Revenue and Share by Players (2014-2019) 3.2 Market Concentration Rate 3.2.1 Top 5 Kidney/Renal Fibrosis Treatment Players Market Share 3.2.2 Top 10 Kidney/Renal Fibrosis Treatment Players Market Share 3.3 Market Competition Trend 4 Global Kidney/Renal Fibrosis Treatment Market Size by Regions 4.1 Global Kidney/Renal Fibrosis Treatment Revenue and Market Share by Regions 4.2 North America Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 4.3 Europe Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 4.4 Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 4.5 South America Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 4.6 Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 5 North America Kidney/Renal Fibrosis Treatment Revenue by Countries 5.1 North America Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019) 5.2 USA Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 5.3 Canada Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 5.4 Mexico Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 6 Europe Kidney/Renal Fibrosis Treatment Revenue by Countries 6.1 Europe Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019) 6.2 Germany Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 6.3 UK Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 6.4 France Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 6.5 Russia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 6.6 Italy Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 7 Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue by Countries 7.1 Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019) 7.2 China Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 7.3 Japan Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 7.4 Korea Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 7.5 India Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 7.6 Southeast Asia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 8 South America Kidney/Renal Fibrosis Treatment Revenue by Countries 8.1 South America Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019) 8.2 Brazil Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 8.3 Argentina Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 8.4 Colombia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 9 Middle East and Africa Revenue Kidney/Renal Fibrosis Treatment by Countries 9.1 Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019) 9.2 Saudi Arabia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 9.3 UAE Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 9.4 Egypt Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 9.5 Nigeria Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 9.6 South Africa Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) 10 Global Kidney/Renal Fibrosis Treatment Market Segment by Type 10.1 Global Kidney/Renal Fibrosis Treatment Revenue and Market Share by Type (2014-2019) 10.2 Global Kidney/Renal Fibrosis Treatment Market Forecast by Type (2019-2024) 10.3 Angiotensin II Receptor Blockers (ARBs) Revenue Growth Rate (2014-2024) 10.4 Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2014-2024) 10.5 Pirfenidone Revenue Growth Rate (2014-2024) 10.6 Renin Inhibitors Revenue Growth Rate (2014-2024) 10.7 Vasopeptidase Inhibitors Revenue Growth Rate (2014-2024) 11 Global Kidney/Renal Fibrosis Treatment Market Segment by Application 11.1 Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Application (2014-2019) 11.2 Kidney/Renal Fibrosis Treatment Market Forecast by Application (2019-2024) 11.3 Commercial/Private Hospitals Revenue Growth (2014-2019) 11.4 Public Health Hospitals Revenue Growth (2014-2019) 11.5 Clinics Revenue Growth (2014-2019) 11.6 Home Treatment Revenue Growth (2014-2019) 12 Global Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2024) 12.1 Global Kidney/Renal Fibrosis Treatment Market Size Forecast (2019-2024) 12.2 Global Kidney/Renal Fibrosis Treatment Market Forecast by Regions (2019-2024) 12.3 North America Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024) 12.4 Europe Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024) 12.5 Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024) 12.6 South America Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024) 12.7 Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024) 13 Research Findings and Conclusion 14 Appendix 14.1 Methodology 14.2 Data Source

List of Tables and Figures Figure Kidney/Renal Fibrosis Treatment Picture Table Product Specifications of Kidney/Renal Fibrosis Treatment Table Global Kidney/Renal Fibrosis Treatment and Revenue (Million USD) Market Split by Product Type Figure Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Types in 2018 Figure Angiotensin II Receptor Blockers (ARBs) Picture Figure Angiotensin Converting Enzyme (ACE) Inhibitors Picture Figure Pirfenidone Picture Figure Renin Inhibitors Picture Figure Vasopeptidase Inhibitors Picture Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Application (2014-2024) Figure Kidney/Renal Fibrosis Treatment Revenue Market Share by Applications in 2018 Figure Commercial/Private Hospitals Picture Figure Public Health Hospitals Picture Figure Clinics Picture Figure Home Treatment Picture Table Global Market Kidney/Renal Fibrosis Treatment Revenue (Million USD) Comparison by Regions 2014-2024 Figure North America Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Europe Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure South America Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Figure Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (2014-2024) Table La Jolla Pharmaceutical Company Basic Information, Manufacturing Base and Competitors Table La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Type and Applications Table La Jolla Pharmaceutical Company Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Genzyme Corporation Basic Information, Manufacturing Base and Competitors Table Genzyme Corporation Kidney/Renal Fibrosis Treatment Type and Applications Table Genzyme Corporation Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Pfizer Inc. Basic Information, Manufacturing Base and Competitors Table Pfizer Inc. Kidney/Renal Fibrosis Treatment Type and Applications Table Pfizer Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Merck & Co. Basic Information, Manufacturing Base and Competitors Table Merck & Co. Kidney/Renal Fibrosis Treatment Type and Applications Table Merck & Co. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Galectin Therapeutics Basic Information, Manufacturing Base and Competitors Table Galectin Therapeutics Kidney/Renal Fibrosis Treatment Type and Applications Table Galectin Therapeutics Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table F. Hoffman-La Roche Ltd. Basic Information, Manufacturing Base and Competitors Table F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Type and Applications Table F. Hoffman-La Roche Ltd. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table ProMetic Life-Sciences Inc. Basic Information, Manufacturing Base and Competitors Table ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Type and Applications Table ProMetic Life-Sciences Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table InterMune Inc. Basic Information, Manufacturing Base and Competitors Table InterMune Inc. Kidney/Renal Fibrosis Treatment Type and Applications Table InterMune Inc. Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table BioLine Rx Ltd Basic Information, Manufacturing Base and Competitors Table BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Type and Applications Table BioLine Rx Ltd Kidney/Renal Fibrosis Treatment Revenue, Gross Margin and Market Share (2017-2018) Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Players (2014-2019) Table Global Kidney/Renal Fibrosis Treatment Revenue Share by Players (2014-2019) Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Players in 2017 Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Players in 2018 Figure Global Top 5 Players Kidney/Renal Fibrosis Treatment Revenue Market Share in 2018 Figure Global Top 10 Players Kidney/Renal Fibrosis Treatment Revenue Market Share in 2018 Figure Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate (%) (2014-2019) Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Regions (2014-2019) Table Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Regions (2014-2019) Figure Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Regions (2014-2019) Figure Global Kidney/Renal Fibrosis Treatment Revenue Market Share by Regions in 2018 Figure North America Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Europe Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure South America Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Table North America Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019) Table North America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019) Figure North America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019) Figure North America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018 Figure USA Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Canada Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Mexico Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Table Europe Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Countries (2014-2019) Figure Europe Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019) Figure Europe Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018 Figure Germany Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure UK Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure France Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Russia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Italy Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Table Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Countries (2014-2019) Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019) Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018 Figure China Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Japan Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Korea Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure India Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Southeast Asia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Table South America Kidney/Renal Fibrosis Treatment Revenue by Countries (2014-2019) Table South America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019) Figure South America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019) Figure South America Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018 Figure Brazil Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Argentina Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Colombia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Table Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Countries (2014-2019) Table Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries (2014-2019) Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Share by Countries in 2018 Figure Saudi Arabia Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure UAE Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Egypt Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure Nigeria Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Figure South Africa Kidney/Renal Fibrosis Treatment Revenue and Growth Rate (2014-2019) Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) by Type (2014-2019) Table Global Kidney/Renal Fibrosis Treatment Revenue Share by Type (2014-2019) Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Type (2014-2019) Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Type in 2018 Table Global Kidney/Renal Fibrosis Treatment Revenue Forecast by Type (2019-2024) Figure Global Kidney/Renal Fibrosis Treatment Market Share Forecast by Type (2019-2024) Figure Global Angiotensin II Receptor Blockers (ARBs) Revenue Growth Rate (2014-2019) Figure Global Angiotensin Converting Enzyme (ACE) Inhibitors Revenue Growth Rate (2014-2019) Figure Global Pirfenidone Revenue Growth Rate (2014-2019) Figure Global Renin Inhibitors Revenue Growth Rate (2014-2019) Figure Global Vasopeptidase Inhibitors Revenue Growth Rate (2014-2019) Table Global Kidney/Renal Fibrosis Treatment Revenue by Application (2014-2019) Table Global Kidney/Renal Fibrosis Treatment Revenue Share by Application (2014-2019) Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Application (2014-2019) Figure Global Kidney/Renal Fibrosis Treatment Revenue Share by Application in 2018 Table Global Kidney/Renal Fibrosis Treatment Revenue Forecast by Application (2019-2024) Figure Global Kidney/Renal Fibrosis Treatment Market Share Forecast by Application (2019-2024) Figure Global Commercial/Private Hospitals Revenue Growth Rate (2014-2019) Figure Global Public Health Hospitals Revenue Growth Rate (2014-2019) Figure Global Clinics Revenue Growth Rate (2014-2019) Figure Global Home Treatment Revenue Growth Rate (2014-2019) Figure Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) and Growth Rate Forecast (2019-2024) Table Global Kidney/Renal Fibrosis Treatment Revenue (Million USD) Forecast by Regions (2019-2024) Figure Global Kidney/Renal Fibrosis Treatment Revenue Market Share Forecast by Regions (2019-2024) Figure North America Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024) Figure Europe Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024) Figure Asia-Pacific Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024) Figure South America Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024) Figure Middle East and Africa Kidney/Renal Fibrosis Treatment Revenue Market Forecast (2019-2024)

La Jolla Pharmaceutical Company Genzyme Corporation Pfizer Inc. Merck & Co. Galectin Therapeutics F. Hoffman-La Roche Ltd. ProMetic Life-Sciences Inc. InterMune Inc. BioLine Rx Ltd